All posts by John McDermott

Dr John McDermott BSc, PGCert, MRes, MBChB, MRCP (London), is an Honorary Clinical Lecturer in Genomic Medicine and a Clinical Genetics Trainee at the Manchester Centre for Genomic Medicine. He has a research interest in the application of genomic data in the acute and critical care setting, specifically focusing on the application of pharmacogenetics (PGx) to improve outcomes. You can find him on Twitter as @John_H_McD.

The Emerging Evidence for a Genetic Susceptibility to Severe Covid-19. St Emlyn’s

A defining feature of the COVID-19 pandemic has been the wide spectrum of clinical presentations, ranging from asymptomatic viremia to life-threatening illness.1 Factors such as advancing age and co-morbid status have been shown to strongly correlate

Translate »